The clinical and molecular significance associated with STING signaling in breast cancer
Abstract STING signaling in cancer is a crucial component of response to immunotherapy and other anti-cancer treatments. Currently, there is no robust method of measuring STING activation in cancer. Here, we describe an immunohistochemistry-based assay with digital pathology assessment of STING in t...
Enregistré dans:
Auteurs principaux: | Eileen E. Parkes, Matthew P. Humphries, Elaine Gilmore, Fatima A. Sidi, Victoria Bingham, Su M. Phyu, Stephanie Craig, Catherine Graham, Joseph Miller, Daryl Griffin, Manuel Salto-Tellez, Stephen F. Madden, Richard D. Kennedy, Samuel F. Bakhoum, Stephen McQuaid, Niamh E. Buckley |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6790f073307d4fffbb5fb02a2f06cc1f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
par: Stephanie G. Craig, et autres
Publié: (2021) -
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
par: Su Chul Jang, et autres
Publié: (2021) -
STING Signaling and Skin Cancers
par: Sayaka Sato, et autres
Publié: (2021) -
Management of corneal bee sting
par: Razmjoo H, et autres
Publié: (2011) -
Signalling strength determines proapoptotic functions of STING
par: Muhammet F. Gulen, et autres
Publié: (2017)